Device Trial Radar · NCT06690437
Observational Study for the Evaluation of the Clinical Performance and Safety Profile of the GALAXY FIXATION™ System and Orthofix Implantable Devices: GALAXY Study
Last checked: Nov 20, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3
Actual
Start
Oct 21, 2025
Primary completion
May 4, 2026
Study completion May 4, 2026
Sponsor
- Lead sponsor
- Orthofix s.r.l.Public (OFIX)
- Sponsor type
- Industry
- First posted
- Nov 15, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 29 days
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The GALAXY FIXATIONTM System and Orthofix implantable devices study intends to evaluate the clinical performance and safety profile of the study medical/investigational devices in the standard clinical practice. The study will be conducted in three sites located in Italy considered reference sites for the treatment of adults and paediatric patients with fractures of the long bones, vertically stable pelvic fractures, or vertically unstable pelvic fractures as a treatment adjunct, where the usage of GALAXY FIXATION™ System and Orthofix implantable devices were part of the normal clinical practice. The participant investigators will retrospectively include a maximum of 118 patients in which GALAXY FIXATIONTM System and Orthofix implantable devices were used. No diagnostic or therapeutic intervention outside routine clinical practice will be applied.
Conditions
- Fractures of the Long Bones
- Vertically Stable Pelvic Fractures
- Vertically Unstable Pelvic Fractures
Interventions
Galaxy Fixation System and Orthofix implantable devicesDevice
It is planned to include 118 patients in 3 sites in Italy treated with GALAXY FIXATION™ System and Orthofix implantable devices for the following indications: * fractures of the long bones or; * Vertically stable pelvic fractures or vertically unstable pelvic fractures as a treatment adjunct Clinical data will be collected only from patients with a regular indication for GALAXY FIXATION™ System and Orthofix implantable devices as per IFUs (no off-label use will be included) and who underwent surgery performed with the specific devices.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The clinical performance of GALAXY FIXATION™ System and Orthofix implantable devices.Time frame: average of 2 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Spedali Civili di Brescia
Brescia, Italy
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.